
|Articles|June 15, 2003
Subconjunctival botulinum toxin helps treat eyelid retraction
Author(s)Cheryl Guttman
London-Subconjunctival injection of botulinum toxin type A (Botox, Allergan) can offer an effective treatment for upper eyelid retraction associated with thyroid eye dis-ease, said Jimmy M. Uddin, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























